🟢 Pershing Square is trading at 4.7% up today after co-leading Precision Neuroscience's $250 million financing

Pershing Square is trading 4.7% higher at $54.75 after co-leading Precision Neuroscience’s oversubscribed $250 million Series D financing.

• The round values the brain-computer-interface company at just over $1 billion; Pershing Square and the Ackman Oxman Institute reportedly contributed $42.5 million.
• The company-specific investment announcement is the clearest catalyst for the September 25, 2026 advance.
• Trading is active during the open session, with no volume figure provided; broader markets are modestly higher.